.svg)
As a Fortune 500 biopharmaceutical company that participates in drug discount programs, Company D faces revenue headwinds from the systemic challenge of noncompliant drug discounts. Company D uses Kalderos’ solution to identify suspected duplicate discount claims that can be submitted to states in a dispute report in order to reclaim lost revenue.
When Company D encountered a challenge from a high-population state regarding the usage of a specific modifier for claims on a dispute report, it did not have the resources or covered entity relationships needed to confirm modifier usage in a timely manner. But with claims-level data from our platform and an established network of covered entity users, Kalderos had the technology and the dedicated team to support Company D’s efforts.
Read our impact study to learn more about how Company D and Kalderos worked together to solve the issue with the state and identify a significant sum for recovery for Company D.
